Events Partner Content Interstitial Lung Disease (ILD) Drug Development Summit Industry Led Conference on Fibrosing ILDs
News BMS swoops on Forbius, snaring another immuno-oncology playe... With the ink barely dry on a deal to develop Dragonfly’s lead cancer immunotherapy, Bristol-Myers Squibb’s business development team has agreed to buy Canadian biotech Forbius
Views & Analysis The promising future of RNA RNA technology-based therapeutics are a new and novel way to treat diseases.
News BMS begins Harvard fibrosis stem cell research collaboration R&D link-up with Harvard Fibrosis Network
News Iambic prices its IPO, seeking to raise up to $160m AI-powered drug discovery company Iambic Therapeutics has announced the terms of its Nasdaq IPO, pitching at a valuation of more than $800m.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
